Blauvelt, A. , Iversen, L., McBride, S. , Gooderham, M., Staubach, P., Yamauchi, P., Staelens, F., Vanoorden, V., White, K. and Gisondi, P. 2021. Bimekizumab versus secukinumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Results from the multicenter, randomized, double-blinded phase 3b BE RADIANT trial. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s53. DOI:https://doi.org/10.25251/skin.5.supp.53.